medigraphic.com
ISSN 2954-3835 (Digital)
ISSN 2683-2828 (Impreso)

2021, Número 2

<< Anterior Siguiente >>

Cardiovasc Metab Sci 2021; 32 (2)


Eventos cardiovasculares mayores en revascularización coronaria fallida versus exitosa en pacientes con oclusión total crónica

López VAJ, Bernal REA, Bautista LGR, Hernández PAA, Hernández GMA

Idioma: Inglés [English version]
Referencias bibliográficas: 33
Paginas: 82-93
Archivo PDF: 400.58 Kb.


RESUMEN

Introducción: Las oclusiones coronarias crónicas se asocian con un impacto negativo en el pronóstico a largo plazo. Objetivos: Conocer si existe diferencia en los eventos cardiovasculares mayores en pacientes sometidos a revascularización exitosa vs revascularización fallida de lesiones de oclusión total crónica en angina estable. Material y métodos: Estudio correlacional, transversal, con dos grupos independientes. Resultados: Se evaluaron 71 pacientes, en un contexto de angina crónica estable, en la Unidad Médica de Alta Especialidad del Bajío, del periodo de enero de 2013 a febrero de 2020, se obtuvieron 41 pacientes con revascularización exitosa (RE) y 30 con revascularización fallida (RF). La tasa de éxito de revascularización fue de 57.7%. La tasa de eventos cardiovasculares mayores encontrados entre pacientes con RE vs RF en este estudio fueron: eventos de angina inestable postrevascularización en 12.5% del grupo RE y en 13.3% del grupo RF (p = 0.918). El grupo de revascularización exitosa tuvo ausencia de infartos agudos al miocardio y en 3.3% del grupo RF (p = 0.245) sí hubo. Ocurrió muerte de origen cardiaco en 0% del grupo RE y en 3.3% del grupo RF (p = 0.245). Mientras que tuvieron necesidad de nueva vascularización el 0% del grupo RE y el 6.7% de los pacientes del grupo RF. La tasa de supervivencia de pacientes con RF fue de 96.7% y en pacientes con RE fue de 100%. Conclusiones: La revascularización exitosa vs fallida no demostró diferencias estadísticamente significativas en la tasa de eventos cardiovasculares mayores


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Fefer P, Knudtson ML, Cheema AN et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol. 2012; 59 (11): 991-997.

  2. Christopoulos G, Karmpaliotis D, Alaswad K et al. Application and outcomes of a hybrid approach to chronic total occlusion 30 percutaneous coronary intervention in a contemporary multicenter US registry. Int J Cardiol. 2015; 198: 222-228.

  3. Stefan P. Schumacher, Wijnand J. Stuijfzand. Percutaneous coronary intervention of chronic total occlusions: When and how to treat. Cardiovascular Revasc Med. 2019; 20 (6): 513-522.

  4. Rinfret S, Dautov R. Radial or femoral approach for chronic total occlusion revascularization: the answer is both. JACC Cardiovasc Interv. 2017; 10 (3): 244-246.

  5. BrilakisES,BanerjeeS,KarmpaliotisDetal.Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry). JACC Cardiovasc Interv. 2015; 8 (2): 245-253.

  6. Hendry C, Fraser D, Eichhofer J et al. Coronary perforation in the drug-eluting stent era: incidence, risk factors, management and outcome: the UK experience. EuroIntervention. 2012; 8 (1): 79-86.

  7. ImMH, YuLH, TanakaHetal.Experiencewithanovel retrograde wiring technique for coronary chronic total occlusion. J Interv Cardiol. 2013; 26 (3): 254-258.

  8. Rinfret S, Joyal D, Spratt JC et al.Chronictotalocclusion percutaneous coronary intervention case selection and techniques for the antegrade-only operator. Catheter Cardiovasc Interv. 2015; 85 (3): 408-415.

  9. Maeremans J, Walsh S, Knaapen P et al. The hybrid algorithm for treating chronic total occlusions In Europe: the RECHARGE registry. J Am Coll Cardiol. 2016; 68 (18): 1958-1970.

  10. George S, Cockburn J, Clayton TC et al. Long-term J Thorac Dis 2018; 10 (5): 2960-2967. Journal of Thoracic Disease, Vol 10, No 5 May 2018 2967 follow-up of elective chronic total coronary occlusion angioplasty: analysis from the U.K. Central Cardiac Audit Database. J Am Coll Cardiol. 2014; 64: 235-243.

  11. Khan MF, Brilakis ES, Wendel CS et al. Comparison of procedural complications and in-hospital clinical outcomes between patients with successful and failed percutaneous intervention of coronary chronic total occlusions: a meta-analysis of observational studies. Catheter Cardiovasc Interv. 2015; 85 (5): 781-794.

  12. Azzalini L, Dautov R, Ojeda S et al. Procedural and long-term outcomes of percutaneous coronary intervention for in-stent chronic total occlusion. JACC Cardiovasc Interv. 2017; 10 (9): 892-902.

  13. Christofferson RD, Lehmann KG, Martin GV et al. Effect of chronic total coronary occlusion on treatment strategy. Am J Cardiol. 2005; 95: 1088-1091.

  14. Maeremans J, Dens J, Spratt JC et al. Antegrade dissection and reentry as part of the hybrid chronic total occlusion revascularization strategy: a subanalysis of the RECHARGE registry (Registry of CrossBoss and Hybrid Procedures in France, the Netherlands, Belgium and United Kingdom). Circ Cardiovasc Interv. 2017; 10 (6): e004791.

  15. Danek BA, Karatasakis A, Karmpaliotis D et al. Use of antegrade dissection re-entry in coronary chronic total occlusion percutaneous coronary intervention in a contemporary multicenter registry. Int J Cardiol. 2016; 214: 428-437.

  16. Azzalini L, Dautov R, Brilakis ES et al. Procedural and longer-term outcomes of wire- versus device-based antegrade dissection and reentry techniques for the percutaneous revascularization of coronary chronic total occlusions. Int J Cardiol. 2017; 231: 78-83.

  17. Whitlow PL, Burke MN, Lombardi WL et al. Use of a novel crossing and re-entry system in coronary chronic total occlusions that have failed standard crossing techniques: results of the FAST-CTOs (Facilitated Antegrade Steering Technique in Chronic Total Occlusions) trial. JACC Cardiovasc Interv. 2012; 5 (4): 393-401.

  18. Christopoulos G, Kandzari DE, Yeh RW et al. Development and validation of a novel scoring system for predicting technical success of chronic total occlusion percutaneous coronary interventions: the PROGRESS CTO (Prospective Global Registry for the Study of Chronic Total Occlusion Intervention) score. JACC Cardiovasc Interv. 2016; 9 (1): 1-9.

  19. Maeremans J, Spratt JC, Knaapen P et al. Towards a contemporary , comprehensive scoring system for determining technical outcomes of hybrid percutaneous chronic total occlusion treatment: the RECHARGE score. Catheter Cardiovasc Interv. 2018; 91 (2): 192-202.

  20. Werner GS, Gitt AK, Zeymer U et al. Chronic total coronary occlusions in patients with stable angina pectoris: impact on therapy and outcome in present 32 day clinical practice. Clin Res Cardiol. 2009; 98: 435-441.

  21. Windecker S, Kolh P, Alfonso F et al. 2014 ESC/ EACTS Guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014; 35: 2541- 2619.

  22. Levine GN, Bates ER, Blankenship JC et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011; 58: e44-122.

  23. Ramunddal T, Hoebers LP, Henriques JP et al. Chronic total occlusions in Sweden-a report from the Swedish Coronary Angiogra- phy and Angioplasty Registry (SCAAR). PLoS One. 2014; 9 (8): e103850.

  24. Michael TT, Karmpaliotis D, Brilakis ES et al. Procedural outcomes of revascularization of chronic total occlusion of native coronary arteries (from a multicenter United States registry). Am J Cardiol. 2013; 112: 488-492.

  25. Henriques JP, Hoebers LP, Ramunddal T et al. Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: The EXPLORE Trial. J Am Coll Cardiol. 2016; 68: 1622-1632.

  26. Galassi AR, Boukhris M, Tomasello SD et al. Long-term clinical and angiographic outcomes of the mini-STAR technique as a bailout strategy for percutaneous coronary intervention of chronic total occlusion. Can J Cardiol. 2014; 30: 1400-1406.

  27. Olivari Z, Rubartelli P, Piscione F et al. Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions: data from a multicenter, prospective, observational study (TOAST-GISE). J Am Coll Cardiol. 2003; 41: 1672-1678.

  28. Yingxu Ma, Dongping Li, Jiayi Li et al. Percutaneous coronary intervention versus optimal medical therapy for patients with chronic total occlusion: a meta-analysis and systematic review. J Thorac Dis. 2018; 10 (5): 2960-2967.

  29. Galassi AR, Brilakis ES, Boukhris M et al. Appropriateness of percutaneous revascularization of coronary chronic total occlusions: an overview. Eur Heart J. 2016; 37: 2692-2700.

  30. Serruys PW, Morice MC, Kappetein AP et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009; 360: 961-972.

  31. Hannan EL, Racz M, Holmes DR et al. Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation. 2006; 113: 2406-2412.

  32. Quadri G, D'Ascenzo F, Moretti C et al. Complete or incomplete coronary revascularisation in patients with myocardial infarction and multivessel disease: A propensity score analysis from the "real-life" BleeMACS (bleeding complications in a multicenter registry of patients discharged with diagnosis of acute coronary syndrome) registry. EuroIntervention. 2017; 13: 407-414.

  33. Iannaccone M, D'ascenzo F, Piazza F et al. Optimal medical therapy vs. coronary revascularization for patients presenting with chronic total occlusion: a meta-analysis of randomized controlled trials and propensity score adjusted studies. Catheter Cardiovasc Interv. 2019; 93 (6): E320-E325.




2020     |     www.medigraphic.com